Ethyl Biscoumacetate

Ethyl Biscoumacetate

SCHEMBL1900704

CCOC(=O)C(c1c(O)c2ccccc2oc1=O)c1c(O)c2ccccc2oc1=O.O=C1c2ccccc2C(=O)C1c1ccccc1

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

VKORC1

The experimentally established mechanism targets of Ethyl Biscoumacetate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
VKORC1 known ✓ Q9BQB6 4/20 0.48
ADORA3 P0DMS8 1/20 0.76
NQO1 P15559 2/20 0.58
CYP2C9 P11712 6/20 0.51
ALDH1A1 P00352 2/20 0.50
KDM4E B2RXH2 1/20 0.48
ALB P02768 1/20 0.48
PCSK7 Q16549 1/20 0.48
HSD17B10 Q99714 1/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Biscoumacetate SCHEMBL29359768 0.87 ADORA3 (1.00) ADORA3NQO1CYP2C9ALDH1A1VKORC1
Ethyl Biscoumacetate SCHEMBL42830 0.87 ADORA3 (1.00) ADORA3NQO1CYP2C9ALDH1A1VKORC1
Phenprocoumon SCHEMBL3828265 0.83 CYP2C9 (0.76) NQO1CYP2C9ALDH1A1VKORC1KDM4E
SCHEMBL5107024 0.82 ADORA3 (0.86) ADORA3NQO1CYP2C9ALDH1A1VKORC1
Dicumarol SCHEMBL28086433 0.77 NQO1 (0.71) NQO1CYP2C9ALDH1A1VKORC1PCSK7
Warfarin SCHEMBL2762070 0.76 CYP2C9 (0.69) NQO1CYP2C9ALDH1A1VKORC1KDM4E
SCHEMBL1647635 0.76 ADORA3 (0.77) ADORA3NQO1CYP2C9ALDH1A1VKORC1
SCHEMBL5106117 0.74 ADORA3 (0.70) ADORA3NQO1CYP2C9ALDH1A1VKORC1
SCHEMBL14078678 0.74 ADORA3 (0.70) ADORA3NQO1CYP2C9ALDH1A1VKORC1
SCHEMBL23044113 0.73 ADORA3 (0.59) ADORA3NQO1CYP2C9ALDH1A1VKORC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2323627-A1 NOVEL RAPID-EFFECT PHARMACEUTICAL FORMS AND USES OF RESULTING PHARMACEUTICAL COMPOSITIONS Bionetwork (FR) 2011-05-25 EP disclosed
WO-2010007232-A9 NOVEL RAPID-EFFECT PHARMACEUTICAL FORMS AND USES OF RESULTING PHARMACEUTICAL COMPOSITIONS BIONETWORK (FR) 2010-03-11 WO disclosed
WO-2010007232-A1 NOVEL RAPID-EFFECT PHARMACEUTICAL FORMS AND USES OF RESULTING PHARMACEUTICAL COMPOSITIONS BIONETWORK (FR) 2010-01-21 WO disclosed
WO-1997004749-A1 METHOD FOR PREPARING DRY PHARMACEUTICAL FORMS, AND RESULTING PHARMACEUTICAL COMPOSITIONS LABORATOIRES EFFIK (FR) 1997-02-13 WO disclosed